PER 0.00% 8.5¢ percheron therapeutics limited

Others can spin it negatively - that's their prerogative.To me...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 725 Posts.
    lightbulb Created with Sketch. 136
    Others can spin it negatively - that's their prerogative.

    To me it is simply great news.

    As others have already pointed out the FDA focus is on "When" not "If".

    Together ANP and the FDA will just review if non-clinical issues may affect the timing. So obviously it has been determined that there are no current/outstanding clinical issues preventing the final phase testing.

    They are saying to ANP ... "When can you get ready for your Phase 2B/3" .. it's that simple.

    GLTAH
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢
Change
0.000(0.00%)
Mkt cap ! $88.12M
Open High Low Value Volume
8.5¢ 8.6¢ 8.3¢ $50.76K 597.0K

Buyers (Bids)

No. Vol. Price($)
2 35000 8.4¢
 

Sellers (Offers)

Price($) Vol. No.
8.6¢ 96543 1
View Market Depth
Last trade - 10.44am 13/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.